39 results
DEF 14A
NMRA
Neumora Therapeutics Inc.
25 Apr 24
Definitive proxy
4:05pm
”), we have elected to provide access to our Annual Meeting materials, which include this Proxy Statement and our Annual Report on Form 10-K for the year … Availability will contain instructions on how to access and review the Annual Meeting materials and will also contain instructions on how to request
10-K
2023 FY
NMRA
Neumora Therapeutics Inc.
7 Mar 24
Annual report
4:05pm
, this group may determine whether a trial may move forward at designated check points based on access to certain data from the trial. There are also … procedures to prioritize access to new medicines that will benefit patients, including a 150-day assessment and a rolling review procedure. All existing EU
8-K
EX-99.1
NMRA
Neumora Therapeutics Inc.
8 Jan 24
Regulation FD Disclosure
8:32am
, Competition, Market Access, Compliance “… 15-25% or up to 30% are reasonable discounts [for navacaprant] a few years after launch, given it’s a new MoA
10-Q
2023 Q3
NMRA
Neumora Therapeutics Inc.
1 Nov 23
Quarterly report
4:05pm
and an antagonist of the Vasopressin 1a Receptor (NMRA-511) for the treatment of agitation in Alzheimer's disease. The Company also gained access to a cloud … of the outstanding equity of Syllable Life Sciences, Inc. (Syllable). The Company acquired Syllable to gain access the rights granted to Syllable under
S-8
EX-99.1
c9ujlb
19 Sep 23
Registration of securities for employees
9:57pm
8-K
EX-3.2
a67zk9d2b7 bgwc
19 Sep 23
Amendments to Articles of Incorporation or Bylaws
4:16pm
424B4
4daf11
18 Sep 23
Prospectus supplement with pricing info
4:12pm
S-1/A
EX-1.1
0dvpd
11 Sep 23
IPO registration (amended)
6:07am
S-1/A
kfvd2sf lj
11 Sep 23
IPO registration (amended)
6:07am
S-1
mhug5vt5ufp
25 Aug 23
IPO registration
5:03pm
S-1
EX-2.2
avlm1 h03x
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.1
qov57npl41
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.3
wdd6b1vqg
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.5
qbwxsb oc
25 Aug 23
IPO registration
5:03pm
S-1
EX-3.3
3pjcetah7r8r9gyrye02
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.6
zlop f48zp
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.4
j20t428v7rl 8nm
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.14
4wduu40tjtz18u kxv
25 Aug 23
IPO registration
5:03pm
S-1
EX-2.1
6emz4fd5pjlerl0l
25 Aug 23
IPO registration
5:03pm